Gilad Oren

Track

Insider profile

Performance

Overall performance
2.2
Performance over holding periods
2.2
30 days 90 days 120 days
Average return -0% 8.2% 15.1%
Success rate 9% 68% 82%
Transactions
7 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Gilad Oren's trades of Aprea Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Purchase
Price
40.06
Quantity 18,705 -1.4%
Value US$3,131,266
Transaction date
Purchase
Price
233.13
Quantity 37,811 +8.1%
Value US$347,489
Transaction date
Purchase
Price
2.90
Quantity 250 +0.1%
Value US$725
Transaction date
Purchase
Price
2.59
Quantity 1,000 +0.3%
Value US$2,590
Transaction date
Purchase
Price
2.54
Quantity 150 +0.0%
Value US$381
Transaction date
Purchase
Price
7.29
Quantity 2,000 +0.6%
Value US$14,580
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-02-02 2026-01-30
B Purchase
79,843 +19.5%
477.45
US$318,037 		79,843 +19.5% 477.45 US$318,037
2025-04-04 2025-04-03
B Purchase
18,705 -1.4%
40.06
US$3,131,266 		18,705 -1.4% 40.06 US$3,131,266
2025-04-04 2025-04-03
B Purchase
37,811 +8.1%
233.13
US$347,489 		37,811 +8.1% 233.13 US$347,489
2024-10-24 2024-10-23
B Purchase
500 +0.2%
3.92
US$1,958 		500 +0.2% 3.92 US$1,958
2024-10-16 2024-10-15
B Purchase
250 +0.1%
2.90
US$725 		250 +0.1% 2.90 US$725
2024-10-15 2024-10-14
B Purchase
1,000 +0.3%
2.59
US$2,590 		1,000 +0.3% 2.59 US$2,590
2024-10-15 2024-10-10
B Purchase
150 +0.0%
2.54
US$381 		150 +0.0% 2.54 US$381
2024-03-14 2024-03-13
B Purchase
2,000 +0.6%
7.29
US$14,580 		2,000 +0.6% 7.29 US$14,580